Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (580)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
160
2025
2949
11.390
Why?
Antibodies, Monoclonal
26
2024
462
6.280
Why?
Hematopoietic Stem Cell Transplantation
28
2024
555
3.430
Why?
Antineoplastic Agents
18
2024
1178
3.310
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1003
3.290
Why?
Humans
213
2025
50389
2.240
Why?
Thalidomide
24
2024
374
2.010
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
112
1.900
Why?
Neoplasm Recurrence, Local
15
2024
634
1.810
Why?
Immunotherapy, Adoptive
9
2024
162
1.780
Why?
Killer Cells, Natural
8
2024
106
1.750
Why?
Transplantation, Autologous
26
2024
464
1.740
Why?
Interleukin-6
12
2023
266
1.660
Why?
Neoplasm Proteins
13
2022
321
1.590
Why?
Hematologic Neoplasms
3
2022
99
1.580
Why?
Middle Aged
74
2025
12460
1.490
Why?
Antigens, Neoplasm
6
2014
146
1.440
Why?
Clinical Trials as Topic
13
2022
465
1.430
Why?
Stem Cell Transplantation
10
2022
179
1.350
Why?
Prognosis
45
2024
1979
1.310
Why?
Aged
74
2025
9590
1.300
Why?
Gene Expression Regulation, Neoplastic
20
2022
830
1.260
Why?
Combined Modality Therapy
19
2024
641
1.250
Why?
Chromosomes, Human, Pair 1
9
2023
92
1.240
Why?
Herpesvirus 8, Human
7
2021
95
1.210
Why?
Translocation, Genetic
10
2022
263
1.170
Why?
Adult
54
2025
13568
1.130
Why?
Treatment Outcome
47
2024
5230
1.130
Why?
Male
84
2025
25718
1.120
Why?
B-Cell Maturation Antigen
8
2024
92
1.120
Why?
Female
86
2025
26981
1.110
Why?
Boronic Acids
12
2013
182
1.100
Why?
Pyrazines
12
2013
187
1.100
Why?
Bone Marrow
18
2024
356
1.050
Why?
Proteasome Inhibitors
5
2024
104
1.040
Why?
Antibodies, Bispecific
5
2024
74
1.000
Why?
Immunotherapy
6
2024
235
0.990
Why?
Gene Expression Profiling
26
2023
1029
0.990
Why?
Neoplasms, Second Primary
2
2024
74
0.970
Why?
Disease-Free Survival
24
2019
450
0.940
Why?
B-Lymphocytes
5
2024
175
0.910
Why?
Dexamethasone
14
2024
437
0.900
Why?
T-Lymphocytes, Cytotoxic
4
2014
64
0.890
Why?
Melphalan
9
2020
173
0.880
Why?
Cancer Vaccines
3
2010
78
0.860
Why?
Follow-Up Studies
26
2024
2219
0.850
Why?
Plasma Cells
11
2023
221
0.830
Why?
Hyperhidrosis
1
2022
2
0.830
Why?
Sweat
1
2022
7
0.820
Why?
Survival Rate
24
2020
915
0.800
Why?
Lymphoma, B-Cell
3
2022
61
0.790
Why?
Drug Approval
1
2022
47
0.780
Why?
Ehrlichia chaffeensis
1
2021
4
0.750
Why?
Patient Participation
1
2022
68
0.750
Why?
T-Lymphocytes
8
2024
331
0.740
Why?
Ehrlichiosis
1
2021
14
0.740
Why?
Cryosurgery
1
2021
36
0.740
Why?
Immunoglobulin Light Chains
3
2017
82
0.730
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
27
0.720
Why?
Embolization, Therapeutic
1
2021
88
0.700
Why?
Cell Proliferation
10
2023
989
0.680
Why?
Disease Progression
16
2023
823
0.680
Why?
Chromosomal Instability
1
2019
16
0.660
Why?
Membrane Proteins
3
2006
348
0.650
Why?
Neoplasms, Plasma Cell
3
2024
37
0.650
Why?
Survival Analysis
18
2024
671
0.640
Why?
Adrenal Cortex Hormones
2
2023
100
0.640
Why?
Immunologic Factors
2
2018
111
0.620
Why?
Neoplasm, Residual
8
2022
161
0.610
Why?
Epigenesis, Genetic
4
2023
374
0.610
Why?
Tumor Microenvironment
6
2024
223
0.610
Why?
Chromosome Aberrations
12
2023
295
0.600
Why?
Dendritic Cells
3
2014
133
0.590
Why?
POEMS Syndrome
1
2018
31
0.590
Why?
Atrial Fibrillation
2
2022
189
0.590
Why?
Thyroid Neoplasms
1
2019
113
0.580
Why?
Polymorphism, Single Nucleotide
3
2024
482
0.570
Why?
Prealbumin
2
2014
21
0.570
Why?
Antibodies, Monoclonal, Humanized
6
2023
224
0.560
Why?
Positron-Emission Tomography
7
2022
289
0.550
Why?
Receptors, Interleukin-6
2
2014
22
0.540
Why?
Cardiomyopathies
2
2014
119
0.510
Why?
Mutation
10
2022
1292
0.500
Why?
Aged, 80 and over
19
2024
3180
0.490
Why?
Osteolysis
4
2022
75
0.480
Why?
Immunotoxins
1
2014
6
0.460
Why?
Drug Resistance, Neoplasm
7
2024
318
0.460
Why?
Risk Factors
20
2025
3692
0.460
Why?
Recurrence
13
2024
664
0.460
Why?
Cytotoxicity, Immunologic
2
2012
56
0.450
Why?
Clonal Evolution
3
2020
56
0.450
Why?
Practice Guidelines as Topic
4
2023
460
0.440
Why?
Cyclophosphamide
5
2021
164
0.430
Why?
Transplantation, Homologous
5
2017
140
0.420
Why?
Amyloidosis
1
2014
78
0.420
Why?
Health Status
1
2015
299
0.420
Why?
Thrombocytopenia
3
2025
84
0.420
Why?
Fluorodeoxyglucose F18
6
2021
190
0.410
Why?
Genome-Wide Association Study
3
2024
163
0.400
Why?
Remission Induction
13
2021
206
0.400
Why?
Neutropenia
2
2023
114
0.390
Why?
Receptors, KIR
2
2008
13
0.390
Why?
Genetic Predisposition to Disease
3
2024
509
0.380
Why?
Bone Diseases
3
2021
97
0.370
Why?
Dose-Response Relationship, Drug
8
2020
1356
0.370
Why?
Pyrimidines
2
2022
193
0.370
Why?
Azacitidine
1
2010
34
0.360
Why?
Benzamides
1
2010
51
0.360
Why?
Evolution, Molecular
2
2021
97
0.350
Why?
Histone Deacetylase Inhibitors
1
2010
57
0.350
Why?
C-Reactive Protein
6
2022
143
0.340
Why?
Prednisone
2
2021
101
0.340
Why?
Doxorubicin
6
2021
234
0.340
Why?
TOR Serine-Threonine Kinases
2
2020
77
0.330
Why?
Drug Administration Schedule
5
2015
369
0.330
Why?
Chromosome Deletion
5
2023
140
0.320
Why?
Metaphase
4
2016
45
0.320
Why?
Pelvis
2
2021
67
0.320
Why?
Vaccination
4
2022
275
0.320
Why?
Quality of Life
1
2015
844
0.320
Why?
Membrane Glycoproteins
2
2009
244
0.310
Why?
Lymph Nodes
4
2025
258
0.310
Why?
Paraproteinemias
3
2022
72
0.310
Why?
Animals
15
2024
13173
0.310
Why?
Proportional Hazards Models
7
2024
418
0.310
Why?
Placebo Effect
2
2020
16
0.300
Why?
Bone Neoplasms
4
2013
179
0.300
Why?
Adoptive Transfer
1
2007
30
0.290
Why?
Histocompatibility Antigens Class I
1
2007
44
0.290
Why?
Chromatin
3
2023
138
0.290
Why?
CD8-Positive T-Lymphocytes
3
2024
123
0.290
Why?
Cytogenetic Analysis
5
2023
80
0.280
Why?
Registries
4
2025
539
0.280
Why?
DNA Methylation
4
2023
551
0.280
Why?
Boron Compounds
2
2024
19
0.280
Why?
Risk Assessment
9
2022
1258
0.270
Why?
Chromans
2
2024
35
0.270
Why?
Vincristine
3
2021
85
0.270
Why?
Young Adult
7
2025
4064
0.270
Why?
Mice, SCID
6
2013
173
0.270
Why?
Cell Membrane
1
2007
249
0.270
Why?
Glycine
2
2024
78
0.270
Why?
Angiogenesis Inhibitors
5
2010
182
0.270
Why?
Down-Regulation
1
2007
343
0.260
Why?
In Situ Hybridization, Fluorescence
5
2023
256
0.260
Why?
Neoplasm Staging
6
2024
750
0.260
Why?
Cell Line, Tumor
9
2023
1399
0.250
Why?
Disease Management
2
2018
175
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
36
0.250
Why?
Vitamin E
2
2024
77
0.250
Why?
Transplantation Conditioning
5
2008
82
0.250
Why?
Mice
11
2024
5688
0.250
Why?
Case-Control Studies
6
2024
1148
0.250
Why?
Infusions, Intravenous
3
2015
213
0.250
Why?
Bone Resorption
2
2022
302
0.250
Why?
Antibody Formation
1
2005
51
0.240
Why?
Fever
2
2022
110
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Time Factors
11
2021
2934
0.230
Why?
Flow Cytometry
4
2012
475
0.230
Why?
Monocytes
2
2020
131
0.230
Why?
Gene Expression
2
2018
613
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
168
0.220
Why?
Ubiquitin-Protein Ligases
1
2024
93
0.220
Why?
Cell Cycle Proteins
2
2022
168
0.220
Why?
Blotting, Western
3
2015
587
0.220
Why?
Proteasome Endopeptidase Complex
3
2011
116
0.220
Why?
Epstein-Barr Virus Infections
2
2020
29
0.210
Why?
Signal Transduction
6
2021
1625
0.210
Why?
Syndrome
2
2025
239
0.210
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Integrin beta Chains
1
2023
13
0.210
Why?
Prospective Studies
8
2022
2414
0.210
Why?
Integrins
1
2023
30
0.210
Why?
Double-Blind Method
2
2015
682
0.210
Why?
Cross-Sectional Studies
3
2023
1590
0.210
Why?
Sweating
1
2022
7
0.210
Why?
Hematopoietic Stem Cells
2
2022
182
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Consensus
2
2020
159
0.200
Why?
Proteomics
3
2021
299
0.200
Why?
Kaplan-Meier Estimate
10
2016
466
0.200
Why?
DNA, Intergenic
1
2022
7
0.200
Why?
Tumor Cells, Cultured
4
2013
462
0.200
Why?
Receptors, Antigen, T-Cell
1
2022
49
0.200
Why?
Tumor Suppressor Protein p53
2
2017
214
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
United States
4
2022
4913
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
91
0.190
Why?
Influenza, Human
1
2022
83
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Mediastinum
1
2021
21
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.190
Why?
Receptors, Glucocorticoid
2
2012
32
0.190
Why?
Phosphatidylinositol 3-Kinases
2
2019
139
0.190
Why?
Ubiquitination
1
2021
41
0.190
Why?
Apoptosis
5
2018
1094
0.190
Why?
Axilla
1
2021
91
0.190
Why?
Alleles
3
2021
253
0.180
Why?
Multiple Organ Failure
1
2021
47
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
85
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
104
0.180
Why?
Salvage Therapy
6
2013
136
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Adolescent
7
2025
6475
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.180
Why?
Rare Diseases
1
2020
43
0.180
Why?
Interferon-gamma
3
2014
176
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Cytokines
2
2014
606
0.170
Why?
Radiopharmaceuticals
4
2021
205
0.170
Why?
Longitudinal Studies
5
2024
709
0.170
Why?
Cell Cycle
1
2021
227
0.170
Why?
Interferon Type I
1
2020
24
0.170
Why?
Myelodysplastic Syndromes
2
2013
79
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Research Design
2
2020
344
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Multivariate Analysis
8
2021
583
0.170
Why?
Health Status Disparities
1
2022
196
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Genomics
4
2023
284
0.170
Why?
Measles virus
1
2019
8
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Measles
1
2019
7
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
DNA
1
2023
543
0.170
Why?
Data Collection
1
2020
283
0.160
Why?
Immunohistochemistry
2
2015
975
0.160
Why?
Oncolytic Virotherapy
1
2019
18
0.160
Why?
Biopsy
5
2018
592
0.160
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
62
0.160
Why?
Retrospective Studies
9
2025
6223
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Cell Differentiation
6
2022
651
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2019
155
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Precancerous Conditions
2
2010
83
0.160
Why?
Evidence-Based Medicine
2
2018
249
0.160
Why?
Graft vs Host Disease
4
2007
73
0.160
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Spleen
1
2019
170
0.150
Why?
Genomic Instability
2
2016
91
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Immunomodulation
1
2018
36
0.150
Why?
Plasma
1
2018
42
0.150
Why?
Chemokines
1
2018
76
0.150
Why?
Myeloablative Agonists
2
2008
30
0.150
Why?
Hematopoietic Stem Cell Mobilization
2
2008
56
0.150
Why?
Genes, Neoplasm
2
2015
30
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Osteoclasts
3
2022
424
0.150
Why?
Models, Biological
2
2018
723
0.150
Why?
Magnetic Resonance Imaging
5
2013
1534
0.150
Why?
Gene Dosage
2
2015
78
0.140
Why?
Gene Rearrangement
1
2018
74
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Communication
1
2019
246
0.140
Why?
Heterozygote
2
2014
83
0.140
Why?
HLA-A Antigens
2
2007
10
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Protein-Tyrosine Kinases
2
2018
95
0.140
Why?
Drug Therapy, Combination
1
2018
383
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
409
0.130
Why?
Gene Frequency
2
2013
95
0.130
Why?
Transcriptome
4
2020
316
0.130
Why?
Syndecan-1
4
2021
72
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Lymphocyte Activation
2
2017
172
0.130
Why?
Critical Illness
1
2018
300
0.130
Why?
Confidence Intervals
2
2014
154
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Immunity, Innate
1
2016
105
0.130
Why?
Erythrocyte Indices
1
2015
7
0.130
Why?
Biomarkers, Pharmacological
2
2012
25
0.130
Why?
DNA Copy Number Variations
3
2022
109
0.130
Why?
Coculture Techniques
2
2013
143
0.120
Why?
Hemoglobins
2
2013
106
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.120
Why?
Hematologic Diseases
1
2014
21
0.120
Why?
International Cooperation
1
2014
45
0.120
Why?
Half-Life
1
2014
85
0.120
Why?
Fatigue
1
2015
118
0.120
Why?
Iron
1
2015
122
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.110
Why?
Area Under Curve
1
2014
179
0.110
Why?
Antibodies
2
2024
151
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Reference Values
1
2014
312
0.110
Why?
ROC Curve
1
2014
239
0.110
Why?
Severity of Illness Index
2
2014
963
0.110
Why?
Renal Insufficiency
2
2021
108
0.110
Why?
Disease Models, Animal
2
2016
1419
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.110
Why?
Emotions
1
2015
166
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Inflammation Mediators
1
2014
110
0.110
Why?
Cisplatin
4
2013
275
0.110
Why?
Macaca mulatta
2
2024
92
0.110
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.110
Why?
Central Nervous System Neoplasms
1
2013
64
0.110
Why?
beta Catenin
1
2013
101
0.100
Why?
Venous Thrombosis
2
2004
88
0.100
Why?
Oligopeptides
1
2013
95
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
64
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Mental Health
1
2015
222
0.100
Why?
Cell Survival
2
2020
590
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Maintenance Chemotherapy
1
2012
49
0.100
Why?
Pain
1
2015
374
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
183
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
197
0.100
Why?
Interleukin-2
1
2012
70
0.100
Why?
Models, Genetic
2
2016
174
0.100
Why?
Cell Movement
1
2013
246
0.100
Why?
Mice, Inbred NOD
1
2012
94
0.100
Why?
Immunoenzyme Techniques
1
2012
141
0.100
Why?
Hemangioma
1
2013
84
0.100
Why?
Soft Tissue Neoplasms
1
2012
56
0.100
Why?
Genotype
1
2013
539
0.090
Why?
Arkansas
5
2021
1991
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
45
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
226
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
53
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
19
0.090
Why?
Secondary Prevention
1
2010
79
0.090
Why?
Interleukin-4
1
2010
44
0.090
Why?
Up-Regulation
4
2018
449
0.090
Why?
HIV Seropositivity
1
2010
27
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
16
0.090
Why?
Immunity, Cellular
1
2010
69
0.090
Why?
Adjuvants, Immunologic
1
2010
51
0.090
Why?
Cell Line
2
2013
1010
0.090
Why?
Cells, Cultured
3
2013
1589
0.080
Why?
Ovarian Neoplasms
1
2014
450
0.080
Why?
Etoposide
2
2007
71
0.080
Why?
Transplantation, Heterologous
1
2009
75
0.080
Why?
Placenta
1
2011
135
0.080
Why?
Radiography
4
2012
485
0.080
Why?
Histones
2
2021
296
0.080
Why?
Hospitalization
2
2024
668
0.080
Why?
Polymerase Chain Reaction
1
2010
456
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.080
Why?
Transcription Factors
2
2023
566
0.080
Why?
Bone and Bones
3
2021
477
0.080
Why?
Haplotypes
1
2008
82
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Liver Neoplasms
1
2012
331
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
60
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Gene Deletion
1
2009
267
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
Neoplastic Stem Cells
1
2009
100
0.080
Why?
Ligands
1
2008
203
0.080
Why?
Osteogenesis
1
2011
353
0.070
Why?
Twins
1
2007
33
0.070
Why?
Busulfan
1
2007
19
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Herpesviridae Infections
2
2019
53
0.070
Why?
Immunophenotyping
1
2007
111
0.070
Why?
Leukocytes, Mononuclear
1
2007
113
0.070
Why?
Caspases
2
2018
104
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Blood Proteins
1
2007
77
0.070
Why?
Skin Neoplasms
1
2012
487
0.070
Why?
Creatinine
1
2007
144
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
223
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.070
Why?
Cohort Studies
3
2020
1426
0.070
Why?
Plasmacytoma
1
2006
40
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
MicroRNAs
1
2010
350
0.070
Why?
Amiloride
1
2005
8
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
112
0.060
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Sensitivity and Specificity
1
2007
875
0.060
Why?
Japan
1
2025
27
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Predictive Value of Tests
3
2018
934
0.060
Why?
Tomography, X-Ray Computed
2
2023
1160
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
4
0.060
Why?
Piperidones
1
2024
6
0.060
Why?
Enoxaparin
1
2004
27
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Retreatment
1
2024
57
0.060
Why?
NF-kappa B
2
2018
315
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Morpholines
1
2024
66
0.060
Why?
Cost of Illness
1
2024
113
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Neoplasms
1
2014
1237
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
54
0.050
Why?
Epidemiologic Methods
3
2008
49
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Gene Silencing
2
2016
114
0.050
Why?
Fibroblasts
1
2005
354
0.050
Why?
Cluster Analysis
3
2010
231
0.050
Why?
Cell Communication
1
2023
69
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
48
0.050
Why?
Geography
1
2022
61
0.050
Why?
Phenotype
1
2025
736
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Whole-Body Irradiation
1
2022
129
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
19
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Primary Cell Culture
1
2022
61
0.050
Why?
Patient Selection
1
2023
257
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
35
0.050
Why?
Risk
2
2014
316
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Anticoagulants
1
2004
254
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Age of Onset
2
2013
108
0.050
Why?
Child, Preschool
2
2020
3908
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Rabbits
2
2013
375
0.050
Why?
RANK Ligand
1
2022
184
0.050
Why?
Polymorphism, Genetic
1
2022
181
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Edema
1
2021
68
0.040
Why?
Fibrosis
1
2021
179
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Spatio-Temporal Analysis
1
2020
9
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Base Sequence
1
2022
657
0.040
Why?
Repressor Proteins
1
2022
149
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Genome, Human
1
2021
111
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Genetic Loci
1
2020
44
0.040
Why?
Mice, Transgenic
1
2021
543
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Incidence
2
2013
1017
0.040
Why?
Europe
1
2019
77
0.040
Why?
Herpesvirus 4, Human
1
2019
39
0.040
Why?
Communicable Disease Control
1
2019
36
0.040
Why?
RNA, Messenger
2
2016
1101
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
Virus Diseases
1
2019
40
0.040
Why?
Genome, Viral
1
2019
79
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
74
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Immunoglobulin G
1
2018
185
0.040
Why?
Oncogene Proteins, Fusion
1
2018
59
0.040
Why?
Data Interpretation, Statistical
2
2010
159
0.040
Why?
Databases, Factual
2
2013
667
0.040
Why?
Child
2
2020
6877
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Glomerular Filtration Rate
1
2017
114
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
181
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
19
0.030
Why?
Internationality
1
2017
40
0.030
Why?
Amino Acid Sequence
1
2018
579
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
75
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
Proteolysis
1
2016
96
0.030
Why?
Enzyme Activation
1
2016
272
0.030
Why?
Chromosome Mapping
2
2006
158
0.030
Why?
Prevalence
1
2019
970
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Phosphorylation
1
2016
527
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Myocardium
1
2017
444
0.030
Why?
Asymptomatic Diseases
1
2014
37
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
53
0.030
Why?
Cerebrospinal Fluid
1
2013
30
0.030
Why?
Homozygote
1
2013
56
0.030
Why?
Genetic Vectors
1
2014
127
0.030
Why?
Nicotinamide Mononucleotide
1
2013
3
0.030
Why?
Diagnosis, Differential
1
2017
1042
0.030
Why?
Acrylamides
1
2013
7
0.030
Why?
Receptors, CXCR4
1
2013
27
0.030
Why?
Niacinamide
1
2013
23
0.030
Why?
Dependovirus
1
2014
102
0.030
Why?
Amides
1
2013
36
0.030
Why?
NAD
1
2013
42
0.030
Why?
Enzyme Induction
1
2013
79
0.030
Why?
Nitriles
1
2013
52
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
31
0.030
Why?
Gene Knockdown Techniques
1
2013
106
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
RNA, Small Interfering
1
2013
210
0.030
Why?
Piperidines
1
2013
96
0.020
Why?
Infant
1
2020
3601
0.020
Why?
Induction Chemotherapy
1
2012
60
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Acute Disease
1
2013
370
0.020
Why?
HIV Infections
1
2016
355
0.020
Why?
Chemokine CXCL10
1
2011
19
0.020
Why?
Antibodies, Neutralizing
1
2011
62
0.020
Why?
Sex Factors
1
2013
702
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
44
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
43
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Microarray Analysis
1
2010
73
0.020
Why?
International Classification of Diseases
1
2010
64
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
120
0.020
Why?
Oligonucleotides
1
2010
81
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
70
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Neoplasm Metastasis
1
2009
235
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
86
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
556
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
213
0.020
Why?
Age Distribution
1
2007
170
0.020
Why?
Recombinant Proteins
1
2008
482
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
180
0.020
Why?
Brain
1
2013
1313
0.020
Why?
Survivors
1
2006
120
0.020
Why?
Pregnancy
1
2011
2610
0.010
Why?
Probability
1
2003
165
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Administration, Oral
1
2003
432
0.010
Why?
Tissue Donors
1
2003
112
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description